Literature DB >> 21586563

High-yield expression of a catalytically active membrane-bound protein: human P450 oxidoreductase.

Duanpen Sandee1, Walter L Miller.   

Abstract

P450 oxidoreductase (POR) is a two-flavin protein that reduces microsomal P450 enzymes and some other proteins. Preparation of active bacterially expressed human POR for biochemical studies has been difficult because membrane-bound proteins tend to interact with column matrices. To reduce column-protein interactions and permit more vigorous washing, human POR lacking 27 N-terminal residues (N-27 POR) was modified to carry a C-terminal Gly3His6-tag (N-27 POR-G3H6). When expressed in Escherichia coli, N-27 POR-G3H6 could be purified to apparent homogeneity by a modified, single-step nickel-nitrilotriacetic acid affinity chromatography, yielding 31 mg POR per liter of culture, whereas standard purification of native N-27 POR required multiple steps, yielding 5 mg POR per liter. Both POR proteins had absorption maxima at 375 and 453 nm and both reduced cytochrome c with indistinguishable specific activities. Using progesterone as substrate for bacterially expressed purified human P450c17, the Michaelis constant for 17α-hydroxylase activity supported by N-27 POR or N-27 POR-G3H6 were 1.73 or 1.49 μm, and the maximal velocity was 0.029 or 0.026 pmol steroids per picomole P450 per minute, respectively. Using 17-hydroxypregnenolone as the P450c17 substrate, the Michaelis constant for 17,20 lyase activity using N-27 POR or N-27 POR-G3H6 was 1.92 or 1.89 μm and the maximal velocity was 0.041 or 0.042 pmol steroid per picomole P450 per minute, respectively. Thus, N-27 POR-G3H6 is equally active as native N-27 POR. This expression and purification system permits the rapid preparation of large amounts of highly pure, biologically active POR and may be generally applicable for the preparation of membrane-bound proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21586563      PMCID: PMC3115607          DOI: 10.1210/en.2011-0230

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  30 in total

1.  Activities and kinetic mechanisms of native and soluble NADPH-cytochrome P450 reductase.

Authors:  D C Lamb; A G Warrilow; K Venkateswarlu; D E Kelly; S L Kelly
Journal:  Biochem Biophys Res Commun       Date:  2001-08-10       Impact factor: 3.575

2.  Metal chelate affinity chromatography, a new approach to protein fractionation.

Authors:  J Porath; J Carlsson; I Olsson; G Belfrage
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

3.  Resolution of the cytochrome P-450-containing omega-hydroxylation system of liver microsomes into three components.

Authors:  A Y Lu; K W Junk; M J Coon
Journal:  J Biol Chem       Date:  1969-07-10       Impact factor: 5.157

4.  Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.

Authors:  Dorota Tomalik-Scharte; Dominique Maiter; Julia Kirchheiner; Hannah E Ivison; Uwe Fuhr; Wiebke Arlt
Journal:  Eur J Endocrinol       Date:  2010-09-15       Impact factor: 6.664

5.  Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic Acid homeostasis.

Authors:  Diana M E Otto; Colin J Henderson; Dianne Carrie; Megan Davey; Thomas E Gundersen; Rune Blomhoff; Ralf H Adams; Cheryll Tickle; C Roland Wolf
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

6.  Purification and characterization of a soluble form of rat liver NADPH-cytochrome P-450 reductase highly expressed in Escherichia coli.

Authors:  Shunsuke Hayashi; Yoshiaki Omata; Hiroshi Sakamoto; Takayuki Hara; Masato Noguchi
Journal:  Protein Expr Purif       Date:  2003-05       Impact factor: 1.650

7.  High-level expression of porcine liver cytochrome P-450 reductase catalytic domain in Escherichia coli by modulating the predicted local secondary structure of mRNA.

Authors:  Shigenobu Kimura; Takashi Iyanagi
Journal:  J Biochem       Date:  2003-09       Impact factor: 3.387

8.  Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome.

Authors:  Christa E Flück; Toshihro Tajima; Amit V Pandey; Wiebke Arlt; Kouji Okuhara; Charles F Verge; Ethylin Wang Jabs; Berenice B Mendonça; Kenji Fujieda; Walter L Miller
Journal:  Nat Genet       Date:  2004-02-01       Impact factor: 38.330

9.  Membrane protein expression and production: effects of polyhistidine tag length and position.

Authors:  Arun K Mohanty; Michael C Wiener
Journal:  Protein Expr Purif       Date:  2004-02       Impact factor: 1.650

10.  One-step metal-affinity purification of histidine-tagged proteins by temperature-triggered precipitation.

Authors:  Hana Stiborova; Jan Kostal; Ashok Mulchandani; Wilfred Chen
Journal:  Biotechnol Bioeng       Date:  2003-06-05       Impact factor: 4.530

View more
  15 in total

1.  Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.

Authors:  Yi Jin; Mo Chen; Trevor M Penning; Walter L Miller
Journal:  Biochem J       Date:  2015-05-15       Impact factor: 3.857

2.  Expression in Escherichia Coli, Purification, and Functional Reconstitution of Human Steroid 5α-Reductases.

Authors:  Hwei-Ming Peng; Juan Valentín-Goyco; Sang-Choul Im; Bing Han; Jiayan Liu; Jie Qiao; Richard J Auchus
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

3.  Minor activities and transition state properties of the human steroid hydroxylases cytochromes P450c17 and P450c21, from reactions observed with deuterium-labeled substrates.

Authors:  Francis K Yoshimoto; Yishan Zhou; Hwei-Ming Peng; David Stidd; Jennifer A Yoshimoto; Kamalesh K Sharma; Susan Matthew; Richard J Auchus
Journal:  Biochemistry       Date:  2012-08-27       Impact factor: 3.162

4.  Catalytically relevant electrostatic interactions of cytochrome P450c17 (CYP17A1) and cytochrome b5.

Authors:  Hwei-Ming Peng; Jiayan Liu; Sarah E Forsberg; Hong T Tran; Sean M Anderson; Richard J Auchus
Journal:  J Biol Chem       Date:  2014-10-14       Impact factor: 5.157

5.  Cytochrome P450 17A1 Interactions with the FMN Domain of Its Reductase as Characterized by NMR.

Authors:  D Fernando Estrada; Jennifer S Laurence; Emily E Scott
Journal:  J Biol Chem       Date:  2015-12-30       Impact factor: 5.157

6.  Phosphorylation of human cytochrome P450c17 by p38α selectively increases 17,20 lyase activity and androgen biosynthesis.

Authors:  Meng Kian Tee; Walter L Miller
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

7.  Biophysical characterization of Aptenodytes forsteri cytochrome P450 aromatase.

Authors:  Francisco Zarate-Perez; Jesús B Velázquez-Fernández; Gareth K Jennings; Lisa S Shock; Charles E Lyons; John C Hackett
Journal:  J Inorg Biochem       Date:  2018-04-07       Impact factor: 4.155

8.  Two surfaces of cytochrome b5 with major and minor contributions to CYP3A4-catalyzed steroid and nifedipine oxygenation chemistries.

Authors:  Hwei-Ming Peng; Richard J Auchus
Journal:  Arch Biochem Biophys       Date:  2013-11-17       Impact factor: 4.013

9.  Structural and Functional Evaluation of Clinically Relevant Inhibitors of Steroidogenic Cytochrome P450 17A1.

Authors:  Elyse M Petrunak; Steven A Rogers; Jeffrey Aubé; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2017-04-03       Impact factor: 3.922

10.  Catalytic modulation of human cytochromes P450 17A1 and P450 11B2 by phospholipid.

Authors:  Hwei-Ming Peng; Chase Barlow; Richard J Auchus
Journal:  J Steroid Biochem Mol Biol       Date:  2018-03-13       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.